Aptevo Therapeutics Inc. (APVO)
USD 4.29
(2.14%)
USD 4.29
(2.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 3.11 Million | 12.29 Million | 4.3 Million | 32.42 Million | 23.06 Million |
| Cost of Revenue | 567 Thousand | 901 Thousand | 18.99 Million | 17.85 Million | 19.92 Million | 11.21 Million |
| Gross Profit | -567 Thousand | 2.21 Million | -6.7 Million | -13.54 Million | 12.49 Million | 11.85 Million |
| Operating Expenses | 28.87 Million | 31.75 Million | 33.69 Million | 31.8 Million | 40.96 Million | 63.51 Million |
| Selling, General and Administrative Expenses | 11.77 Million | 13.87 Million | 14.69 Million | 13.95 Million | 16.19 Million | 28.13 Million |
| Research and Development Expenses | 16.54 Million | 17.88 Million | 18.99 Million | 17.85 Million | 24.76 Million | 35.38 Million |
| Other Expenses | - | -1.52 Million | -8 Million | -1.32 Million | -2.1 Million | -2.02 Million |
| Cost and Expenses | 28.87 Million | 31.75 Million | 33.69 Million | 31.8 Million | 40.96 Million | 74.73 Million |
| Operating Income | -28.87 Million | -28.64 Million | -21.4 Million | -27.49 Million | -40.96 Million | -51.66 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -35.65 Million | -2.09 Million | -12.47 Million | -2.61 Million | -2.02 Million |
| Earnings before Tax | -18.65 Million | 7.01 Million | -29.4 Million | -30.92 Million | -43.06 Million | -53.68 Million |
| Net Income | -17.41 Million | 42.66 Million | -27.31 Million | -18.44 Million | -40.44 Million | -53.68 Million |
| Earnings Per Share Basic | -62.62 | 366.71 | -256.35 | -239.38 | -610.11 | -1469.88 |
| Earnings Per Share Diluted | -62.62 | 367.92 | -256.35 | -239.38 | -610.11 | -1469.88 |
| Weighted Average Shares Outstanding | 278.06 Thousand | 116.35 Thousand | 106.54 Thousand | 77.06 Thousand | 66.29 Thousand | 36.52 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 278.06 Thousand | 115.97 Thousand | 106.54 Thousand | 77.06 Thousand | 66.29 Thousand | 36.52 Thousand |
| Gross Margin | - | 0.71 | -0.55 | -3.14 | 0.39 | 0.51 |
| EBIT Margin | - | -20.85 | -1.74 | -5.89 | -1.19 | -2.14 |
| Profit Margin | - | 13.70 | -2.22 | -4.28 | -1.25 | -2.33 |
| EBITDA | -28.31 Million | -27.74 Million | -20.25 Million | -26.08 Million | -39.52 Million | -49.27 Million |
| Earnings Before Tax Margin | - | -9.20 | -1.74 | -6.38 | -1.26 | -2.24 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 902 Thousand | - | - |
| Cost of Revenue | 91 Thousand | 106 Thousand | 567 Thousand | 116 Thousand | 123 Thousand | 150 Thousand |
| Gross Profit | -91 Thousand | -106 Thousand | -567 Thousand | 786 Thousand | -123 Thousand | -150 Thousand |
| Operating Expenses | 5.93 Million | 6.87 Million | 28.31 Million | 6.26 Million | 6.56 Million | 8.17 Million |
| Selling, General and Administrative Expenses | 2.38 Million | 3.23 Million | - | 2.79 Million | 2.67 Million | 2.71 Million |
| Research and Development Expenses | 3.55 Million | 3.64 Million | - | 3.47 Million | 3.88 Million | 5.46 Million |
| Other Expenses | 141 Thousand | 149 Thousand | - | 188 Thousand | 227 Thousand | 230 Thousand |
| Cost and Expenses | 6.02 Million | 6.98 Million | 28.87 Million | 6.38 Million | 6.56 Million | 8.17 Million |
| Operating Income | -6.02 Million | -6.98 Million | -28.87 Million | -6.38 Million | -6.56 Million | -8.17 Million |
| Interest Expense | - | - | - | 9.58 Million | - | - |
| Income Tax Expense | - | 62.72 Thousand | -1.23 Million | -293 Thousand | 162.58 Thousand | 27.91 Thousand |
| Earnings before Tax | -5.88 Million | -6.83 Million | -18.65 Million | -6.19 Million | -6.33 Million | -7.94 Million |
| Net Income | -5.88 Million | -6.83 Million | -17.41 Million | -5.9 Million | -6.33 Million | -7.94 Million |
| Earnings Per Share Basic | -1.67 | -9.95 | - | -11.85 | -22.16 | -54.12 |
| Earnings Per Share Diluted | -1.67 | -9.95 | - | -11.85 | -22.16 | -53.95 |
| Weighted Average Shares Outstanding | 3.51 Million | 686.73 Thousand | 278.06 Thousand | 498.16 Thousand | 285.88 Thousand | 146.85 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 3.51 Million | 686.73 Thousand | 278.06 Thousand | 498.16 Thousand | 285.88 Thousand | 147.32 Thousand |
| Gross Margin | - | - | - | 0.87 | - | - |
| EBIT Margin | - | - | - | -6.95 | - | - |
| Profit Margin | - | - | - | -6.54 | - | - |
| EBITDA | -5.93 Million | -6.87 Million | - | -6.26 Million | -6.43 Million | -8.02 Million |
| Earnings Before Tax Margin | - | - | - | -7.08 | - | - |
4568
6138
3123
MAHALXSE
603986
BZLYF